Skip to main content
. 2015 Jun 12;10(6):e0126773. doi: 10.1371/journal.pone.0126773

Table 2. Cognitive measures in HD patients and control subjects.

HD patients Control subjects ρ value
TMT—Part A 81.87±55.20 31.54±27.22 0.000002 (Kruskal-Wallis)
TMT—Part B 226±116.63 80.12±51.74 0.000003 (Kruskal-Wallis)
TMT—Part B-A 154.54±83.57 49.58±29.98 0.000003 (Kruskal-Wallis)
FAB 13.60±3.21 16.53±1.40 0.000068 (Kruskal-Wallis)
RCPM 24.07±5.36 30.49±2.66 0.000011 (Kruskal-Wallis)
MMSE 25.54±2.83 28.00±1.41 0.000332 (Kruskal-Wallis)
Rey’s Imm 29.92±11.00 43.00±7.86 0.000021 (ANOVA)
Rey’s Del 5.76±2.85 8.37±2.26 0.000998 (ANOVA)
Token Test 29.88±3.18 33.29±1.08 0.000019 (Kruskal-Wallis)
Stroop Interf Test (rs) 13.96±9.16 22.92±7.37 0.000519 (ANOVA)
Verbal Phon Flu Test 18.33±10.13 43.79±9.99 0.000001 (ANOVA)
Symbol Digit 22.96±11.06 49.46±13.00 0.000001 (ANOVA)

Data are expressed as mean±SD. TMT: Trail Making Test; FAB: Frontal Assessment Battery; RCPM: Raven Coloured Progressive Matrices; MMSE: Mini-Mental State Examination; Rey’s Imm: Rey's 15 Words Test Immediate Recall; Rey's Del: Rey's 15 Words Test Delayed Recall; Token Test: Token Test; Stroop Int Test (rs): Stroop Colour-Word Interference Test (raw score); Verbal Phon Flu Test: Verbal Phonemic Fluency Test; Symbol Digit: Symbol Digit Modalities Test.